Tegria Taps AI Veteran as CEO to Drive Growth After Altaris Acquisition

SPOKANE, Wash. – June 08, 2026 – In a move signaling a significant strategic pivot, global healthcare consulting firm Tegria has appointed Craig Mengert as its new Chief Executive Officer. The appointment, effective immediately, is more than a simple leadership transition; it is a calculated step that aligns a new, technology-forward vision with the financial firepower of a recent acquisition, positioning the company to aggressively tackle the modernization challenges plaguing the healthcare industry.

Mengert, who will also join the Board of Directors, succeeds Brian Cahill, who is retiring after a 47-year career. Cahill will transition to an independent director role on Tegria’s Board, a move designed to ensure strategic continuity. The change comes on the heels of Tegria's acquisition earlier this year by Altaris, LLC, a healthcare-dedicated investment firm, setting the stage for an accelerated phase of growth and innovation.

A New Architect for an AI-Driven Future

Craig Mengert is not a typical consulting executive. He is an architect of technological transformation with a proven record of embedding emerging technologies, particularly artificial intelligence, into the core of healthcare operations. His more than 30 years in the industry are highlighted by his recent tenure as CEO of TriZetto, a Cognizant company, where he engineered a remarkable turnaround. He inherited an organization with a negative growth rate and steered it to sustained double-digit organic growth, consistently exceeding 14% year-over-year. At TriZetto, he managed a $1 billion profit and loss statement with operating margins over 44%, demonstrating a rare ability to drive both innovation and financial discipline.

His success was rooted in a vision to simplify healthcare through advanced software and data insights. Mengert championed the integration of AI across all TriZetto platforms, focusing on practical applications that reduce administrative burdens. He was a proponent of “agentic AI,” developing tools like the TriZetto Assistant, which is embedded within software to streamline complex administrative workflows. His philosophy, captured in writings on “Governance Before Autonomy,” underscores a commitment to deploying these powerful tools responsibly and securely—a critical concern in the highly regulated healthcare space.

“Craig has spent his career in healthcare leading teams and strengthening client and partner relationships,” said the outgoing CEO, Brian Cahill. “His approachable leadership style, focus on client service, and alignment with our values make him the perfect choice to lead Tegria through its next phase of growth.”

Mengert’s experience at Horizon BlueCross BlueShield of New Jersey gives him a deep, firsthand understanding of the payer side of the healthcare equation. This dual perspective is invaluable for a company like Tegria, which serves both provider and payer organizations. His appointment signals a clear intent to move beyond traditional consulting and become a technology-enabled partner that delivers tangible efficiencies and improved outcomes.

“Tegria is a leading healthcare consulting firm delivering industry-recognized services,” Mengert stated. “I am honored to step into the role of CEO to guide the firm’s next chapter.”

The Altaris Effect: Fueling a Post-Acquisition Power Play

The timing of Mengert’s appointment is no coincidence. It is inextricably linked to Tegria’s acquisition by Altaris, a private equity firm that invests exclusively in the healthcare sector. Altaris operates not as a passive financial backer but as a strategic partner, typically taking control investments in companies poised to improve healthcare outcomes and reduce systemic costs. The acquisition provided Tegria with a significant infusion of capital and a mandate for growth.

This new financial backing is the fuel for the strategic engine Mengert is expected to build. The combination of Altaris’s capital and Mengert’s technological vision creates a powerful synergy. It enables Tegria to invest heavily in research and development, pursue strategic acquisitions of its own, and scale its service offerings globally. For a company with over 1,000 professionals and 650 clients, this backing provides the resources needed to deploy complex, AI-driven solutions at an enterprise level.

This post-acquisition power play positions Tegria to compete more aggressively in a crowded marketplace. While giants like Accenture and Deloitte offer broad consulting services, and specialized firms like Optum Advisory leverage deep payer-provider integration, Tegria’s redefined strategy carves out a distinct niche: practical, scalable AI implementation focused on immediate operational and financial impact.

“I look forward to working with the Board and the entire team to build on the momentum of the Altaris acquisition and to continue delivering long-term value for our clients, employees, and shareholders,” Mengert added, explicitly linking his new role to the firm's enhanced strategic capabilities.

Navigating Healthcare's Digital Frontier

Healthcare providers and payers are at a critical juncture. They face immense pressure to modernize legacy technology infrastructure, reduce soaring operational costs, and meet the rising expectations of consumers for seamless digital experiences. Many are burdened by inefficient administrative processes, from claims processing to prior authorizations, that contribute to clinician burnout and administrative waste.

Tegria’s mission, now amplified under Mengert, is to guide these organizations across the digital frontier. The focus will likely shift from optimizing existing systems to fundamentally re-engineering them with AI at their core. Mengert’s track record suggests a strategy focused on tangible results: using AI to automate repetitive tasks, predictive analytics to identify at-risk patients, and data-driven insights to inform better clinical and financial decisions. This approach aims to transform the role of a clinician from a data-entry clerk into a data-validator, freeing up valuable time for patient care.

The challenge is immense, but so is the opportunity. By combining deep industry expertise with cutting-edge, responsibly governed AI, Tegria is poised to offer solutions that are not just innovative in theory but effective in practice. This focus on demonstrable ROI and improved user experience for both patients and providers will be its key differentiator.

Continuity and Legacy: A Strategic Transition

While the focus is on a new era of innovation, the transition has been carefully managed to preserve institutional knowledge. Brian Cahill’s move to the Board of Directors is a testament to this strategy. Having served as CEO since 2022 and previously leading Cumberland Consulting Group before its acquisition by Tegria, Cahill brings a wealth of experience in technology consulting and a deep understanding of the company's client base.

His continued presence provides a steady hand and strategic continuity, ensuring that the company’s deep-rooted commitment to client service remains intact as it embraces a more aggressive, technology-centric future. This thoughtful transition allows Tegria to build upon its established foundation of trust and expertise while simultaneously accelerating its evolution. The combination of Cahill's strategic oversight and Mengert's transformative vision creates a balanced leadership structure designed to navigate the complexities of the healthcare market and drive sustainable, long-term growth.